FXR1 expression domain in Wilms tumor

Study validates FXR1 RNA-binding protein expression across 82 Wilms tumor specimens, showing universal detection with strongest staining in blastemal components. FXR1 expression appears independent of demographics or histology, suggesting potential as a therapeutic target in this common pediatric kidney cancer.